Improving Glycaemic Control in Malaysian Patients With Type 2 Diabetes Mellitus With Insulin Pump Therapy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 118 participants.

Also called NCT03112538

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 118 participants (planned count) (from the registry)
Sponsor
  • Medtronic Registry lists this organization as a collaborator
Registry
  • NCT NCT03112538
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Malaysia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03112538. Randomized; no masking; primary purpose treatment. Start 2016-01 (actual); primary completion 2018-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Improving Glycaemic Control in Malaysian Patients With Type 2 Diabetes Mellitus With Insulin Pump Therapy
Condition
Type 2 Diabetes Mellitus
Intervention (Device)
Insulin Pump
Intervention (Drug)
Multiple daily injections of insulin
Lead sponsor
Clinical Research Centre, Malaysia (class: other)
Collaborator
Medtronic (class: industry)

Record details

Record id
cardio:ct-nct03112538
Content hash
4b955ae57a0e3c3475bea4af6a30c245cd08ad7c4446eb95d9ccd974a67465b1